BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving research platform. New compounds and evidence are added continuously.
B

Compounds That Target STK17B

Serine/threonine-protein kinase 17B · 19 compounds in BiohacksAI corpus

STK17B (Serine/threonine-protein kinase 17B) is a biological target with 19 documented compound interactions in the BiohacksAI corpus. The compounds listed below have been identified through computational analysis of BindingDB binding assay data and PubMed literature. Each interaction is ranked by confidence score reflecting the breadth and strength of experimental evidence. This resource supports research into STK17B modulation for therapeutic and biohacking applications.

All 19 Compounds — Ranked by Evidence
1
Gefitinib
5.67
confidence
2
Erlotinib
5.55
confidence
3
Alvocidib
4.52
confidence
4
Ruxolitinib
4.23
confidence
5
Midostaurin
3.85
confidence
6
Neratinib
3.66
confidence
7
Nintedanib
3.61
confidence
8
Canertinib
3.53
confidence
9
Pelitinib
3.50
confidence
10
Tae 684
3.43
confidence
11
Fedratinib
3.40
confidence
12
Mln 8054
3.33
confidence
13
Sulfuretin
3.14
confidence
14
Dovitinib
3.09
confidence
15
Lestaurtinib
3.04
confidence
16
R 406
2.83
confidence
17
Pha 665752
2.71
confidence
18
Kw 2449
2.64
confidence
19
Su 014813
2.20
confidence

The compounds above were identified through computational analysis of BindingDB binding assay data and PubMed literature for STK17B (Serine/threonine-protein kinase 17B). Confidence scores reflect the strength and breadth of experimental evidence.

Explore related resources: STK17B target overview · All biological targets · Biological pathways

Data from BindingDB and PubMed. For research purposes only. Not medical advice.